We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

49 hedge funds and large institutions have $44.8M invested in Filana Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

20% more capital invested

Capital invested by funds: $37.2M → $44.8M (+$7.58M)

0% more funds holding

Funds holding: 49 → 49 (0)

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
14
Reduced
14
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$2.41M
2
BI
BVF Inc
California
+$1.75M
3
GIM
Granahan Investment Management
Massachusetts
+$834K
4
Renaissance Technologies
Renaissance Technologies
New York
+$144K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$44.5K

Top Sellers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
-$1.29M
2
Morgan Stanley
Morgan Stanley
New York
-$175K
3
Goldman Sachs
Goldman Sachs
New York
-$163K
4
Millennium Management
Millennium Management
New York
-$140K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$84.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$10.2M +$2.41M +181,978 +28%
First Eagle Investment Management
2
First Eagle Investment Management
New York
$9.95M – – –
SCM
3
Stonepine Capital Management
Oregon
$6.26M +$6.76M +510,714 New
BI
4
BVF Inc
California
$3.24M +$1.75M +131,942 +99%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.43M +$44.5K +3,363 +2%
BIT
6
BlackRock Institutional Trust
California
$2.27M – – –
JGC
7
J. Goldman & Co
New York
$1.59M -$1.29M -97,724 -43%
GIM
8
Granahan Investment Management
Massachusetts
$1.36M +$834K +62,993 +132%
Renaissance Technologies
9
Renaissance Technologies
New York
$1.18M +$144K +10,914 +13%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$1.17M -$78.8K -5,958 -6%
6CM
11
683 Capital Management
New York
$756K – – –
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$688K – – –
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$615K -$5.89K -445 -0.9%
BCM
14
Bridgeway Capital Management
Texas
$588K +$9.26K +700 +1%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$356K +$648 +49 +0.2%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$290K -$741 -56 -0.2%
GF
17
Gabelli Funds
New York
$280K – – –
TA
18
Teton Advisors
New York
$194K – – –
BFA
19
BlackRock Fund Advisors
California
$185K +$7.24K +547 +4%
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$175K – – –
Northern Trust
21
Northern Trust
Illinois
$122K – – –
GI
22
GAMCO Investors
Connecticut
$114K – – –
GS
23
Gagnon Securities
New York
$110K – – –
State Street
24
State Street
Massachusetts
$73K -$2.05K -155 -3%
Connor, Clark & Lunn Investment Management (CC&L)
25
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$65K – – –
1
2

FLNA Hedge Fund Activity: Q4 2015 in Review

49 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2015, worth a combined $44.8M — up 20% from $37.2M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new FLNA positions and 3 closed out — a net gain of 1 holder — while 14 added to existing stakes and 14 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $2.41M. The largest seller was J. Goldman & Co, cutting an estimated $1.29M.

  • 49 institutional investors held Filana Therapeutics (FLNA) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $44.8M of Filana Therapeutics stock for Q4 2015, up 20% quarter-over-quarter.
  • 4 funds opened new Filana Therapeutics positions in Q4 2015 and 3 closed out, a net change of +1 holder.
  • The largest Filana Therapeutics buyer in Q4 2015 was Nantahala Capital Management, an estimated $2.41M added.
  • The largest Filana Therapeutics seller in Q4 2015 was J. Goldman & Co, an estimated $1.29M sold.

Based on aggregated 13F filings for Q4 2015.